Cardioplegia Round Table Discussion: Custodial (EP Video)

A Method to Reduce Allogeneic Blood Exposure and Hospital Costs While Preserving Clotting Factor Concentration After Cardiopulmonary Bypass

The Hemobag® technology allows the open-heart team to safely concentrate the residual CPB circuit contents and quickly return a high volume of clotting factors and blood cells back to the patient.

Association between Perioperative Glucose Levels and Adverse Outcomes in Infants Receiving Open-heart Surgery with Cardiopulmonary Bypass for Congenital Heart Disease

There is no consensus that hyperglycaemia is an independent predictor of morbidity-mortality in children.